# Thrombin activity confinement and dense granule release drive the dynamics of arterial thrombus

**Authors:** Efim S. Bershadsky, Dmitry Y. Nechipurenko

PMC · DOI: 10.1371/journal.pcbi.1014062 · 2026-03-20

## TL;DR

A new computational model explains how thrombin activity and platelet granule release control the structure and growth of arterial blood clots.

## Contribution

A 3D computational model reveals how thrombin confinement and dense granule depletion regulate thrombus dynamics and structure.

## Key findings

- Thrombus core size is regulated by thrombin transport and platelet activation thresholds.
- ADP concentration dynamics and granule pool depletion explain three-stage thrombus growth.
- The model explains reduced thrombus core size in Hermansky-Pudlak syndrome and hemostasis in penetrating injuries.

## Abstract

The mechanisms driving spatial heterogeneity of arterial thrombus and its three-stage dynamics are poorly understood. To investigate the potential principles regulating the size of the thrombus core and shell we developed a 3D continuum computational model that describes thrombus heterogeneity, thrombin-induced platelet dense granule secretion and clot propagation through thrombin and ADP-induced platelet activation. The continuum model predicted that spatial confinement of the thrombus core was a result of thrombin transport and a threshold-like dependence of platelet activation on thrombin concentration. This new model recapitulated three-stage dynamics observed in vivo and explained it with a burst-like ADP concentration dynamics due to the confinement of thrombus core propagation and rapid dense granule pool depletion within the core. The maximal shell size in silico was regulated by the transport of ADP and the kinetics of thrombin-dependent dense granules secretion. Simulations also predicted that partial propagation of thrombin inside the thrombus shell caused irreversible platelet activation by the low-dose thrombin and defined the residual shell size. Moreover, our results provided an explanation for the reduced size of a thrombus core observed in the mouse models of Hermansky-Pudlak syndrome. The continuum model was then applied to describe a FeCl3-induced thrombosis in macrocirculation, and described the thrombin-flux-depending switch between occlusive and non-occlusive thrombosis scenarios in mouse carotid artery. Finally, our simulations reinforced the hypothesis suggesting the importance of the large ADP-dependent thrombus shell for sealing the breach in case of a penetrating injury. Taken together, our results suggest a novel mechanism that may regulate arterial thrombus dynamics and offer several insights and сlarification to the core-and-shell model of arterial thrombus organization, as well as a possible role of the large thrombus shell in hemostasis.

Arterial thrombus is heterogeneous and exhibits complex spatiotemporal dynamics, however, the complete understanding of the underlying mechanisms is still missing. Using current knowledge of the key processes driving thrombus growth and the existing in vitro data on platelet responses, we developed a computational model that offered a new explanation of arterial thrombus dynamics observed in vivo through the combination of spatial confinement of thrombus core propagation and platelet dense granule pool depletion. Our results bring several new insights into the potential mechanisms that regulate thrombus structure and dynamics in both micro and macrocirculation and suggest an important role of thrombus shell in hemostatic response to the penetrating injuries.

## Linked entities

- **Proteins:** F2 (coagulation factor II, thrombin), WDTC1 (WD and tetratricopeptide repeats 1)
- **Chemicals:** FeCl3 (PubChem CID 24380)
- **Diseases:** Hermansky-Pudlak syndrome (MONDO:0019312)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** F2 (coagulation factor II) [NCBI Gene 14061] {aka Cf-2, Cf2, FII}, Mdga2 (MAM domain containing glycosylphosphatidylinositol anchor 2) [NCBI Gene 320772] {aka 6720489L24Rik, 9330209L04Rik, Adp, Mamdc1, Tg(Prnp-PFN1*G118V)838Kiaei}, Proc (protein C) [NCBI Gene 19123] {aka PC}, Selp (selectin, platelet) [NCBI Gene 20344] {aka CD62P, GMP-140, Grmp, LECAM3, PADGEM}, F2 (coagulation factor II, thrombin) [NCBI Gene 280685], Serpinc1 (serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1) [NCBI Gene 11905] {aka ATIII, At-3, At3}, P2ry12 (purinergic receptor P2Y, G-protein coupled 12) [NCBI Gene 70839] {aka 2900079B22Rik, 4921504D23Rik, P2Y12}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Itga2b (integrin alpha 2b) [NCBI Gene 16399] {aka CD41, CD41B, GpIIb, alphaIIb}, A2m (alpha-2-macroglobulin) [NCBI Gene 232345] {aka A2mp}
- **Diseases:** Injury (MESH:D014947), Hermansky-Pudlak syndrome (MESH:D022861), bleeding (MESH:D006470), platelet aggregation (MESH:D001791), Thrombus (MESH:D013927), occlusive (MESH:D001157), vessel occlusion (MESH:C536223)
- **Chemicals:** ADP (MESH:D000244), cangrelor (MESH:C117446), NADP (MESH:D009249), TXA2 (MESH:D013928), ADP0 (-), ATP (MESH:D000255), FeCl3 (MESH:C024555), clopidogrel (MESH:D000077144), serotonin (MESH:D012701)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090]

## Figures

49 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13004377/full.md

---
Source: https://tomesphere.com/paper/PMC13004377